Tender detail

Open-house rebate agreements for medicines containing brivaracetam

Summary

The procurement concerns non-exclusive rebate agreements for medicines containing the active ingredient brivaracetam (ATC N03AX23), under an open-house model. Agreements may be concluded at any time for the period from 1 January 2027 to 31 December 2028. Medicines listed as paediatric medicines by the BfArM under Section 35(5a) SGB V are excluded.

Reference number
808daf96-443f-428a-94e6-bf8f834bb3cd
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-31
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.